XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.9150
0.00 (0.00%)
At close: Jun 6, 2025, 4:00 PM
0.9050
-0.0100 (-1.09%)
After-hours: Jun 6, 2025, 6:40 PM EDT

XORTX Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20 2015 - 2019
Net Income
-0.99-3.31-2.16-7.72-1.58-1.01
Upgrade
Depreciation & Amortization
0.110.120.140.060.010.02
Upgrade
Asset Writedown & Restructuring Costs
-----0.05
Upgrade
Stock-Based Compensation
0.080.120.120.490.460.23
Upgrade
Other Operating Activities
-2.93-0.72-3.66-2.47-2.61-0.14
Upgrade
Change in Accounts Receivable
0.010.040.02-0.04-0.03-
Upgrade
Change in Accounts Payable
0.09-0.13-1.190.89-0.260.32
Upgrade
Change in Other Net Operating Assets
0.610.210.140.62-0.79-0.03
Upgrade
Operating Cash Flow
-3.02-3.68-6.58-8.17-4.8-0.57
Upgrade
Capital Expenditures
---0-0.02--
Upgrade
Sale (Purchase) of Intangibles
-0.04-0.04-0.04-0.03-0.03-0.01
Upgrade
Investing Cash Flow
-0.04-0.04-0.05-0.05-0.03-0.01
Upgrade
Long-Term Debt Repaid
--0.07-0.07-0.02--
Upgrade
Net Debt Issued (Repaid)
-0.08-0.07-0.07-0.02--
Upgrade
Issuance of Common Stock
1.613.520520.070.71
Upgrade
Other Financing Activities
-0.39-0.67-0.3-1.07-0.7-0.03
Upgrade
Financing Cash Flow
1.142.78-0.363.9119.370.67
Upgrade
Foreign Exchange Rate Adjustments
-0.03-0.040-0.140.2-
Upgrade
Net Cash Flow
-1.94-0.97-6.99-4.4414.740.09
Upgrade
Free Cash Flow
-3.02-3.68-6.59-8.19-4.8-0.57
Upgrade
Free Cash Flow Per Share
-0.94-1.28-3.32-5.53-4.39-0.77
Upgrade
Levered Free Cash Flow
-0.56-1.11-3.67-3.8-0.83-1.37
Upgrade
Unlevered Free Cash Flow
-0.56-1.11-3.67-3.8-0.82-1.36
Upgrade
Change in Net Working Capital
-1.03-0.320.79-1.47-0.181.05
Upgrade
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q